IP Library Granted Patent US 12,171,817
Granted Patent B2
US 12,171,817 · App. 18/464,051 · Granted Dec 24, 2024

Antigens for detecting toxoplasma infection by monitoring cellular immunity

Inventors: Laurence David Sibley (St. Louis, MO); Kevin M. Brown (St. Louis, MO); Qiuling Wang (St. Louis, MO); Iti Saraav (St. Louis, MO)
Assignee: Washington University
A61K39/0002A61K39/002A61M5/31531A61K2039/54A61K2039/572A61K2039/6087
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,171,817
App. No.
18/464,051
Granted
Dec 24, 2024
Kind
B2
Abstract

Antigens of Toxoplasma gondii that provide specific and strong delayed type hypersensitivity (DTH) immune response, or which stimulate IFN-γ secretion, are used for testing subjects for infection. Any skin testing format may be adapted for testing for the delayed type hypersensitivity, including a patch, a needle, or a prong. Presence of DTH indicates infection. Alternate methods of detecting a T cell response including monitoring IFN-γ secretion may be used.

Claims (9)

1. An in vitro method of monitoring a T cell response in a T cell from a subject, wherein the subject has not been immunized against Toxoplasma gondii , the method comprising: contacting the T cell of the subject with a composition comprising

a truncated MIC4 comprising the amino acids 58-231 of the amino acid sequence as set forth in SEQ ID NO: 55, or a sequence at least 90% identical thereto; and

detecting or quantifying release of a cytokine.

2. The method of claim 1 wherein the response is a delayed-type hypersensitivity response.

3. The method of claim 1 wherein the response is release of a cytokine.

4. The method of claim 1 wherein the response is release of interferon-γ.

5. The method of claim 1 wherein the T cells are in peripheral blood mononuclear cells.

6. The method of claim 1 wherein the T cells are in a blood sample.

7. The method of claim 1 further comprising the step of detecting or quantifying release of interferon-γ.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2024
From: SIBLEY, LAURENCE DAVID; BROWN, KEVIN; WANG, QIULING; SARAAV, ITI
To: WASHINGTON UNIVERSITY
Reel/Frame 069212/0109 →
Continuity (5)
Division 17742023 · May 11, 2022
Division 16347510
Provisional Application 62417136 · Nov 3, 2016
Provisional Application 62550393 · Aug 25, 2017
Related Publication 20240091327A1 · Mar 21, 2024